Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-01-23 Sale | 2023-01-23 5:10 pm | ALBIREO PHARMA INC. | ALBO | Duncan Jason Chief Legal Officer and GC | 228 | $43.8 | $9,986 | 14,146 (Direct) | View |
| 2023-01-19 Sale | 2023-01-20 4:05 pm | ALBIREO PHARMA INC. | ALBO | Duncan Jason Chief Legal Officer and GC | 938 | $43.9 | $41,182 | 14,374 (Direct) | View |
| 2022-10-24 Sale | 2022-10-25 4:00 pm | ALBIREO PHARMA INC. | ALBO | Duncan Jason Chief Legal Officer and GC | 656 | $19.45 | $12,756 | 14,931 (Direct) | View |
| 2022-07-22 Sale | 2022-07-25 4:12 pm | ALBIREO PHARMA INC. | ALBO | Duncan Jason Chief Legal Officer and GC | 657 | $24.21 | $15,908 | 15,587 (Direct) | View |
| 2022-04-22 Sale | 2022-04-25 4:38 pm | ALBIREO PHARMA INC. | ALBO | Duncan Jason Chief Legal Officer and GC | 655 | $33.22 | $21,758 | 16,008 (Direct) | View |
| 2022-01-24 Sale | 2022-01-25 4:39 pm | ALBIREO PHARMA INC. | ALBO | Duncan Jason Chief Legal Officer and GC | 1,688 | $24.94 | $42,094 | 16,663 (Direct) | View |
| 2021-10-22 Sale | 2021-10-25 6:30 pm | ALBIREO PHARMA INC. | ALBO | Duncan Jason Chief Legal Officer and GC | 312 | $29.1 | $9,079 | 7,355 (Direct) | View |
| 2021-07-22 Sale | 2021-07-26 4:05 pm | ALBIREO PHARMA INC. | ALBO | Duncan Jason Chief Legal Officer and GC | 313 | $32.21 | $10,081 | 7,667 (Direct) | View |
| 2021-06-24 Sale | 2021-06-28 4:01 pm | ALBIREO PHARMA INC. | ALBO | Duncan Jason Chief Legal Officer and GC | 16,300 | $36.32 | $591,986 | 73,017 (Direct) | View |
| 2021-04-22 Sale | 2021-04-26 6:13 pm | ALBIREO PHARMA INC. | ALBO | Duncan Jason Chief Legal Officer and GC | 312 | $32.16 | $10,033 | 7,849 (Direct) | View |
| 2021-03-31 Sale | 2021-04-02 8:55 pm | ALBIREO PHARMA INC. | ALBO | Duncan Jason Chief Legal Officer and GC | 1,726 | $35.24 | $60,816 | 27,361 (Direct) | View |
| 2021-01-22 Sale | 2021-01-25 5:44 pm | ALBIREO PHARMA INC. | ALBO | Duncan Jason Chief Legal Officer and GC | 110 | $34.62 | $3,808 | 33,032 (Direct) | View |
| 2020-10-22 Sale | 2020-10-23 4:19 pm | ALBIREO PHARMA INC. | ALBO | Duncan Jason Chief Legal Officer and GC | 89 | $34.71 | $3,089 | 3,781 (Direct) | View |
| 2020-09-08 Sale | 2020-09-10 8:54 pm | ALBIREO PHARMA INC. | ALBO | Duncan Jason Chief Legal Officer and GC | 4,000 | $45.55 | $182,200 | 23,370 (Direct) | View |
| 2020-07-22 Sale | 2020-07-23 4:23 pm | ALBIREO PHARMA INC. | ALBO | Duncan Jason Chief Legal Officer and GC | 91 | $25.8 | $2,348 | 4,370 (Direct) | View |
| 2020-04-22 Sale | 2020-04-24 5:20 pm | ALBIREO PHARMA INC. | ALBO | Duncan Jason Chief Legal Officer and GC | 92 | $17.68 | $1,627 | 4,461 (Direct) | View |
| 2020-01-22 Sale | 2020-01-23 7:22 pm | ALBIREO PHARMA INC. | ALBO | Duncan Jason Chief Legal Officer and GC | 447 | $23.97 | $10,715 | 36,053 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-12-11 Option Award | 2023-12-12 6:16 pm | N/A 2033-12-10 | Neumora Therapeutics Inc. | NMRA | Duncan Jason Chief Legal Officer | 400,000 | $0 | 400,000 (Direct) | View |
| 2023-03-02 Disposition | 2023-03-02 4:44 pm | N/A 2032-01-17 | ALBIREO PHARMA INC. | ALBO | Duncan Jason Chief Legal Officer and GC | 177,350 | $0 | 0 (Direct) | View |
| 2023-03-02 Equity Swap | 2023-03-02 4:44 pm | N/A N/A | ALBIREO PHARMA INC. | ALBO | Duncan Jason Chief Legal Officer and GC | 3,296 | $0 | 0 (Direct) | View |
| 2023-01-19 Option Award(A) | 2023-01-27 5:26 pm | N/A N/A | ALBIREO PHARMA INC. | ALBO | Duncan Jason Chief Legal Officer and GC | 55,000 | $0 | 69,146 (Direct) | View |
| 2023-01-19 Option Award | 2023-01-25 8:09 pm | N/A N/A | ALBIREO PHARMA INC. | ALBO | Duncan Jason Chief Legal Officer and GC | 55,000 | $0 | 69,146 (Direct) | View |
| 2022-01-18 Option Award | 2022-01-20 4:52 pm | N/A 2032-01-17 | ALBIREO PHARMA INC. | ALBO | Duncan Jason Chief Legal Officer and GC | 26,700 | $0 | 34,251 (Direct) | View |
| 2021-06-24 Exercise | 2021-06-28 4:01 pm | N/A N/A | ALBIREO PHARMA INC. | ALBO | Duncan Jason Chief Legal Officer and GC | 9,137 | $24.04 | 73,017 (Direct) | View |
| 2021-06-24 Exercise | 2021-06-28 4:01 pm | N/A N/A | ALBIREO PHARMA INC. | ALBO | Duncan Jason Chief Legal Officer and GC | 7,163 | $24.67 | 73,017 (Direct) | View |
| 2021-06-24 Exercise | 2021-06-28 4:01 pm | N/A 2029-01-21 | ALBIREO PHARMA INC. | ALBO | Duncan Jason Chief Legal Officer and GC | 16,300 | $0 | 73,017 (Direct) | View |
| 2021-04-01 Exercise | 2021-04-02 8:55 pm | N/A N/A | ALBIREO PHARMA INC. | ALBO | Duncan Jason Chief Legal Officer and GC | 300 | $24.04 | 27,361 (Direct) | View |
| 2021-04-01 Exercise | 2021-04-02 8:55 pm | N/A 2029-01-21 | ALBIREO PHARMA INC. | ALBO | Duncan Jason Chief Legal Officer and GC | 300 | $0 | 27,361 (Direct) | View |
| 2021-01-21 Option Award | 2021-01-25 5:44 pm | N/A 2031-01-20 | ALBIREO PHARMA INC. | ALBO | Duncan Jason Chief Legal Officer and GC | 29,200 | $0 | 33,032 (Direct) | View |
| 2020-09-08 Exercise | 2020-09-10 8:54 pm | N/A N/A | ALBIREO PHARMA INC. | ALBO | Duncan Jason Chief Legal Officer and GC | 3,500 | $24.04 | 23,370 (Direct) | View |
| 2020-09-08 Exercise | 2020-09-10 8:54 pm | N/A 2029-01-21 | ALBIREO PHARMA INC. | ALBO | Duncan Jason Chief Legal Officer and GC | 3,500 | $0 | 23,370 (Direct) | View |
| 2020-01-21 Option Award | 2020-01-23 7:22 pm | N/A 2030-01-20 | ALBIREO PHARMA INC. | ALBO | Duncan Jason Chief Legal Officer and GC | 31,500 | $0 | 36,053 (Direct) | View |